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Abstract
Background:  Affymetrix GeneChips are a popular platform for performing whole-genome
experiments on the transcriptome. There are a range of different calibration steps, and users are
presented with choices of different background subtractions, normalisations and expression
measures. We wished to establish which of the calibration steps resulted in the biggest uncertainty
in the sets of genes reported to be differentially expressed.
Results:  Our results indicate that the sets of genes identified as being most significantly
differentially expressed, as estimated by the z-score of fold change, is relatively insensitive to the
choice of background subtraction and normalisation. However, the contents of the gene list are
most sensitive to the choice of expression measure. This is irrespective of whether the experiment
uses a rat, mouse or human chip and whether the chip definition is made using probe mappings
from Unigene, RefSeq, Entrez Gene or the original Affymetrix definitions. It is also irrespective of
whether both Present and Absent, or just Present, Calls from the MAS5 algorithm are used to filter
genelists, and this conclusion holds for genes of differing intensities. We also reach the same
conclusion after assigning genes to be differentially expressed using t-statistics, although this
approach results in a large amount of false positives in the sets of genes identified due to the small
numbers of replicates typically used in microarray experiments.
Conclusion: The major calibration uncertainty that biologists need to consider when analysing
Affymetrix data is how their multiple probe values are condensed into one expression measure.
Background
Microarrays provide the opportunity to study the tran-
scriptional output of a genome. The most common appli-
cation of microarrays at present is to perform comparative
studies, looking for relative changes between two condi-
tions. The aim of calibration is to minimise as much sys-
tematic and experimental variation in the data, whilst
retaining the biological variation. The calibration of
microarrays, combined with statistics of the changes,
underpins what can be inferred from these studies.
In this paper we focus on the calibration of oligonucle-
otide GeneChip arrays produced by Affymetrix. The cali-
bration process for GeneChips can be considered to have
three parts: background correction; normalisation; expres-
sion measure. Background correction is needed to remove
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the proportion of intensity that is not due to hybridisation
of the target. The normalisation of an array is needed
before it can be compared against other arrays, correcting
for differences in overall mRNA levels and scanner set-
tings. An expression measure is needed to transform the
fluorescence from an array into a measure of the mRNA
abundance.
The aim of differential expression statistics is to highlight
which genes show the most significant changes between
two conditions. Z-scores can be used to measure the sig-
nificance of a gene's fold change with respect to the pop-
ulation of changes seen elsewhere on the array [1]. The use
of t-statistics is also commonly used to report genes that
are differentially expressed. Throughout this work we refer
to background correction, normalisation and expression
measure as calibration and assessment of differential
expression as statistics.
The preprocessing of GeneChips is an active research field
with a number of different algorithms being developed
[2]. This has led to comparative studies of the differences
between different protocols ([2], [3]), with [4] noting the
importance of background correction. Other work has
compared the relative importance of differential statistics
and normalisation and concluded that normalisation was
the limiting factor in determining a set of genes [5]. How-
ever, it has been reported [2] that calibration methods that
differ only in normalization result in practically identical
expression measures. A full calibration includes several
other steps as well as normalisation, and is usually fol-
lowed by estimations of differential expression between
two conditions. Given the uncertainty in the literature we
therefore chose to study all the calibration steps in order
to shed light on which of normalization, background cor-
rection or expression measure has the biggest effect on the
sets of genes reported to be differentially expressed. We
also wished to determine whether our conclusions about
the dominant step depended on the choice of statistics
used to infer differential expression.
A further complication is that some of the probes in a
probeset may map to more than one transcript, and may
not even map to the transcript of interest [6]. Moreover,
information about probe mapping can be derived from
several online resources, and not all of these will be in
agreement [7]. A further complication with mapping is
that some probes map to transcripts that undergo alterna-
tive splicing and alternative polyadenylation [8].
A full calibration protocol can be devised from one of the
choices for each of the various strategies for normalisa-
tion, background correction and expression measures.
Each of these protocols will produce a list of genes that are
measured to be significantly differentially expressed.
However, different protocols can produce different lists
and the end-user biologist may worry that the wrong
choice of protocol is producing misleading conclusions.
We have sought to identify the calibration step which
results in the biggest cause of change.
Results
1) Sensitivity of different calibration protocols
The package affy allows a choice for each of the three pri-
mary calibration steps: three options for background cor-
rection; five choices for normalisation; three different
expression summaries. In total, there are 45 different per-
mutations for calibration (Table 1). After data has been
calibrated, a comparison between two conditions allows
genes to be identified as differentially expressed. We have
used the Z-score method [1] as our statistical measure,
and have collated the genes whose absolute measure of Z
is the largest, i.e. we produce one list that includes both
and up down regulated genes.
In order to assess the agreements in gene lists identified
between different protocols we explored various strate-
gies. We ultimately decided to compare the total amount
of genes common to two lists as being our measure of con-
sensus. For such a comparison we do not care if gene X is
found to be the most significantly changing gene for pro-
tocol A and is found to be the 100th most significantly
changing gene for protocol B, just as long as gene X is
found somewhere in both lists.
In order to provide a visual aid in assessing consensus
between different protocols we have transformed percent
overlap onto a greyscale: 0% overlap between two lists is
coloured black, 100% overlap (the list members are iden-
tical) is coloured white and in between 0 and 100 are dif-
ferent shades of grey. The resulting matrix and
corresponding overlap image is diagonally symmetric.
Figure 1 shows how the agreement between different pro-
tocols, for dataset GSE1004 [9], becomes increasingly
Table 1: Calibration options within Affy
Calibration step Option 1 Option 2 Option 3 Option 4 Option 5
Background subtraction Nothing RMA MAS
Normalisation Constant Invariant set Lowess Qspline Quantiles
Expression Measure Li-Wong (MBEI) Median Polish (RMA) MAS5BMC Bioinformatics 2007, 8:195 http://www.biomedcentral.com/1471-2105/8/195
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noisy as we reduce the size of the gene lists that are com-
pared from 400, to 100, to 30. Given the smoothness
apparent for a list size of 400 genes we kept with this size
for all subsequent comparisons. Figure 1 shows that the
most significant clustering of agreement is that between
different protocols which all have the same expression
measure, whether that be RMA [10], MAS5 [11] or Li-
Wong [12]. Two protocols that differ in background sub-
traction and normalisation, but have a common expres-
sion measure, will share more significant genes in
common than two protocols that differ in expression
measure, but which have a either a common background
subtraction or normalisation or both.
A histogram of the percent overlaps between two gene lists,  produced from: (a) all permutation pairs for the 45 different  protocols, excluding those comparisons between identical  protocols; (b) all permutation pairs for the 45 different pro- tocols which share a common choice of expression measure;  (c) all permutation pairs for the 45 different protocols which  share a common choice of background subtraction excluding  those comparisons between identical protocols; (d) all per- mutation pairs for the 45 different protocols which share a  common choice of normalization excluding those compari- sons between identical protocols Figure 2
A histogram of the percent overlaps between two gene lists, 
produced from: (a) all permutation pairs for the 45 different 
protocols, excluding those comparisons between identical 
protocols; (b) all permutation pairs for the 45 different pro-
tocols which share a common choice of expression measure; 
(c) all permutation pairs for the 45 different protocols which 
share a common choice of background subtraction excluding 
those comparisons between identical protocols; (d) all per-
mutation pairs for the 45 different protocols which share a 
common choice of normalization excluding those compari-
sons between identical protocols.
a) 
b) 
c)
d)
Matrices of consensus in the most significant changing genes  (Z-score) in the 45 different protocols for GSE1004, for dif- ferent cutoffs: (a) Top 400 genes Figure 1
Matrices of consensus in the most significant changing genes 
(Z-score) in the 45 different protocols for GSE1004, for dif-
ferent cutoffs: (a) Top 400 genes. The blocks on consensus 
are labelled LW, RMA and MAS to indicate the choice of 
expression measure.; (b) 400 genes. We have labelled the 
next level of structure None, RMA and MAS, and this level 
indicates the choice of background subtraction.; (c) Top 100 
genes ; (d) Top 30 genes
a) 
b) 
c) 
d) BMC Bioinformatics 2007, 8:195 http://www.biomedcentral.com/1471-2105/8/195
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Figure 2 shows a histogram of percent overlaps for the per-
mutations of different protocols. The average overlap
between gene lists from two calibration protocols is
76.0%. The distribution has four peaks, with the highest
peak indicating comparisons between protocols sharing
the same expression measure. The average overlap for
gene lists produced from just Li-Wong protocols is 87.4 ±
3.4, for just RMA protocols is 88.9 ± 3.2 and for just MAS
protocols is 88.8 ± 4.0. The lowest peak of the distribution
is due to comparisons between protocols in which one
uses MAS and the other uses RMA (compare with Figure
1). The next peak is from comparisons between RMA and
Li-Wong, and the next peak (second highest) is from com-
parisons between Li-Wong and MAS.
For a given expression measure, the choice of background
is more important than the choice of normalisation.
Inspection of figure 1 shows that along the diagonal, col-
lections of boxes of size 5 (due to the normalisation) all
appear to have similar values. The average overlap in gene
lists between protocols sharing the same expression meas-
ure and background subtraction is 92.7 ± 2.7 indicating
that background information makes some improvement
in consistency.
Figure 3 shows matrices of comparisons for experiments
GSE1004 [9], GSE1703 [13], GSE1873 [14], GSE2401
[15] and GSE2535 [16]. We find that differences in the
expression measure is the dominant cause of disagree-
ments in the gene lists between different protocols, irre-
spective of whether the experiment uses a human, rat or
mouse chip, and irrespective of the number of biological
replicates for each condition. If two calibration protocols
share a common expression measure then the average per-
cent overlap in their gene lists is 83% for GSE1703, 77%
for GSE1873, 82% for GSE2401 and 85% for GSE2535.
There exist collations of the information about transcripts
and probes from different online resources [6]. Different
probes from within a probeset may map to more than one
transcript, and may be assigned erroneously to a gene to
which they do not map. There are Chip Definition Files
(CDFs) using mappings to Unigene, RefSeq, Entrez Gene
and Ensemble Transcript amongst others [6]. Further-
more, Affymetrix provide a CDF produced from their orig-
inal mapping. We have assessed whether the gene lists are
strongly affect by the use of different probe mappings,
through analysing GSE1004 using the 8th build of the
CDFs from [6] and the original Affymetrix CDF, Figure 4.
Our results show that irrespective of which CDF is used,
the dominant cause of discrepancy between different gene
lists remains the choice of expression measure. If two cal-
ibration protocols share a common expression measure
then the average percent overlap in their gene lists in the
GSE1004 experiment is 88% for the Affymetrix CDF, 87%
Matrices of consensus in the top 400 most significant chang- ing genes (Z-score) in the 45 different protocols : (a)  GSE1004; (b) GSE1703; (c) GSE1873; (d) GSE2401; (e)  GSE2535 Figure 3
Matrices of consensus in the top 400 most significant chang-
ing genes (Z-score) in the 45 different protocols : (a) 
GSE1004; (b) GSE1703; (c) GSE1873; (d) GSE2401; (e) 
GSE2535.
a) 
b) 
c) 
d) 
e) BMC Bioinformatics 2007, 8:195 http://www.biomedcentral.com/1471-2105/8/195
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for the Ensembl Transcript CDF, 88% for the Entrez Gene
CDF, 86% for the RefSeq CDF and 87% for the Unigene
CDF.
The MAS5 algorithm makes Present/Absent calls for each
probeset. In order to assess whether these calls made a dif-
ference to our conclusions, we made a very conservative
study of GSE1004, only sampling the genes which had
been called present in all the chips. This was true for 2965
of the 12625 probesets. Figure 5 shows how the choice of
expression measure is still the dominant cause of discrep-
ancy between the gene lists for different protocols.
We wished to assess whether our findings are dependent
upon the intensity of the genes. We broke the probesets
for GSE1004 into three groups, those whose average
intensity across the chips, when run with the standard
RMA protocol, is either < 5.5 (4401 probesets), ≥ 5.5 and
< 7 (3853 probesets) or ≥ 7 (4371 probesets). Figure 6
shows the genes with the highest intensity have the high-
est overlap between calibration protocols and those with
the lowest intensity have the least overlap between cali-
bration protocols. Irrespective of intensity, the choice of
Matrices of consensus for those probesets which are all  present in the GSE1004 experiment: (a) for the top 400  genes from each calibration protocol; (b) for the top 100  genes from each calibration protocol Figure 5
Matrices of consensus for those probesets which are all 
present in the GSE1004 experiment: (a) for the top 400 
genes from each calibration protocol; (b) for the top 100 
genes from each calibration protocol.
a) 
b) 
Matrices of consensus in the top 400 most significant chang- ing genes (Z-score) in the 45 different protocols for  GSE1004 using different chip definitions : (a) Affymetrix; (b)  Unigene; (c) Refseq; (d) Entrez Gene; (e) Ensembl Transcript Figure 4
Matrices of consensus in the top 400 most significant chang-
ing genes (Z-score) in the 45 different protocols for 
GSE1004 using different chip definitions : (a) Affymetrix; (b) 
Unigene; (c) Refseq; (d) Entrez Gene; (e) Ensembl Transcript.
a) 
b) 
c) 
d) 
e) BMC Bioinformatics 2007, 8:195 http://www.biomedcentral.com/1471-2105/8/195
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expression measure provides the biggest cause of discrep-
ancy between gene lists produced from different calibra-
tion protocols.
We wished to determine whether our choice of Z-scores,
rather than t-tests, was biasing our conclusions about the
importance of expression measure. We calculated the
most significantly changing genes for each of the five
experiments, evaluated using the standard t-test formal-
ism. Figure 7 shows that the typical discrepancy between
calibration protocols using t-tests is much greater than
found using the Z-score formalism. When an experiment
contains only a few replicates, estimates of the mean and
variance are noisy.
In order to confirm our hypothesis that Z-scores will pro-
vide a cleaner diagnostic than fold change, we calculated
the largest fold changes for each of the five experiments.
Figure 8 shows that for a given choice of background and
expression measure, there is little difference in the gene
lists for different normalisation choices. However, unlike
the results for Z-scores, background choice and expression
measure have a similar effect on the discrepancies
between different calibration protocols.
Matrices of consensus between different calibration proto- cols using t-tests to assess the 400 most significantly differen- tially expressed genes: (a) GSE1004; (b) GSE1703; (c)  GSE1873; (d) GSE2401; (e) GSE2535 Figure 7
Matrices of consensus between different calibration proto-
cols using t-tests to assess the 400 most significantly differen-
tially expressed genes: (a) GSE1004; (b) GSE1703; (c) 
GSE1873; (d) GSE2401; (e) GSE2535.
a) 
b) 
c) 
d) 
e) 
Matrices of consensus for the top 400 genes between differ- ent calibration protocols for GSE1004: (a) genes with small  intensity; (b) genes with medium intensity; (c) genes with  large intensity Figure 6
Matrices of consensus for the top 400 genes between differ-
ent calibration protocols for GSE1004: (a) genes with small 
intensity; (b) genes with medium intensity; (c) genes with 
large intensity.
a) 
b) 
c) BMC Bioinformatics 2007, 8:195 http://www.biomedcentral.com/1471-2105/8/195
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Discussion
Our results indicate that the calculation of the expression
measure is the dominant cause of discrepancies between
genelists produced from different calibration protocols.
The expression measure calculation brings together data
from multiple probes, and each of the probes may have a
systematic error associated with it. Although great
progress has been made, through the developments of
MAS, MBEI and RMA, there are still inherent complica-
tions associated with calibrating Affymetrix data.
The MAS expression measure treats cross-hybridisation
differently to RMA and Li-Wong and this difference will
lead to discrepant estimates in the probe specific back-
ground. Ideally each probe would only map to a specific
part of the sequence of interest, but in reality different
mRNA fragments from various genes can stick to the same
probes. In order to measure such cross-hybridisation
Affymetrix introduced MisMatch probes to their chips.
However, physical models of this process are now becom-
ing available and it is now clear that a significant fraction
of the MisMatch signal arises from hybridisation to tran-
scripts with the PerfectMatch sequence [17]. One model
of this process [17] ignores the order of the base compo-
sition, whereas another model of hybridization [18]
explicitly accounts for the sequence order. Currently, there
is no consensus on the dominant contributions to the
hybridization physics, nor the most appropriate models
in which to describe the effects. It is hoped that the
increasingly detailed physical models of this process, [19],
will shed light on this matter.
The Li-Wong and RMA expression measure used in this
study both explicitly ignore cross-hybridisation and the
only difference between the Li-Wong and RMA genelists
arise from the two ways in which the model of a probe-set
are constructed. RMA provides statistically robust averag-
ing methods whereas Li-Wong fits a model that allows
probe-specific binding affinities. Also, Li-Wong calculates
expression on the original probe intensity values rather
than the log-transformed ones used by RMA. However,
the differences in gene lists between these different expres-
sion measures is still greater than 20% which shows the
importance of the choice for a model and fitting para-
digm. Our results agree with [2] in that we find from stud-
ying fold change (Figure 8), good agreement between
methods that do not correct for background.
In line with other work, e.g. [20], we find that the lowest
intensity genes result in a bigger discrepancy between cal-
ibration protocols, than those genes found with a larger
intensity. Although our evidence from this study is weak,
this is to be expected if the genes reported to be differen-
tially expressed from the lowest intensity genes contain a
larger number of false positives due to noise.
Matrices of consensus between different calibration proto- cols using fold change to assess the 400 most significantly dif- ferentially expressed genes: (a) GSE1004; (b) GSE1703; (c)  GSE1873; (d) GSE2401; (e) GSE2535 Figure 8
Matrices of consensus between different calibration proto-
cols using fold change to assess the 400 most significantly dif-
ferentially expressed genes: (a) GSE1004; (b) GSE1703; (c) 
GSE1873; (d) GSE2401; (e) GSE2535.
a) 
b) 
c) 
d) 
e) BMC Bioinformatics 2007, 8:195 http://www.biomedcentral.com/1471-2105/8/195
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There is an ongoing debate over whether measures of dif-
ferential expression based on either t-statistics [21] or
fold-change [22] formalisms provide the most sensible
way in which to generate gene lists. Microarray experi-
ments typically contain small numbers of replicates,
which means that any t-test formalism will attempt to cal-
culate the mean and variance of a distribution from only
a small number of values. The large numbers of probesets
means that this approach will necessarily result in false
positives when the numbers of replicates is small. Indeed,
Figure 7 is consistent with an experiment in which two
lists are compared, when each list contains a small
number of common genes and a large set of random
genes. We agree with [21], that the use of small sample
sizes can lead to frustration amongst biologists chasing
false leads. Our, somewhat brutual, advice to biologists is
that such frustration is to be expected if your search is
based around following genes identified by t-tests when
you only have a small number of replicates.
We favour the choice of Z-score, rather than fold change,
because we predict this should maintain the advantages of
fold-change, namely reproducibility, as well as explicitly
correcting for the non-linear response curves of microar-
ray data. There are a number of expression measures that
are affected by bias in the lowest and highest intensity
ranges [2], and for each of these measures we recommend
the use of Z-scores over fold change. However, the field of
expression measure development is evolving and the
work of Irizarry and colleagues is leading to measures in
which the bulk of the biases are being removed. In the
absence of intensity-dependence of ratio data Z-score and
fold-change will result in the same ranking order of gene
lists. Similarly, in the limit when the sliding window is set
to 100% of the genes on the array, Z-score and fold change
will result in the same ranking order. We hope that future
work, based around following a similar approach to pre-
vious studies [23], also include an analysis of Z-scores in
comparison to other statistical tests.
Irrespective of whether we use fold change or Z-score, our
results agree with [2], in that we find the choice of normal-
ization measure has little effect on the results compared to
modifying the choice of background or expression meas-
ure. However, [5] suggested that normalization has a pro-
found effect on differentially expressed genes from
Affymetrix microarrays. The analysis of [5] used three sta-
tistical tests, namely parametric ANOVA, nonparametric
ANOVA and SAM [24], each of which uses the small
number of replicates for any gene to estimate statistical
significance. Whereas, we have used Z-scores, which
ignores the calculation to estimate variance in one gene,
and instead only deals with its mean values in each condi-
tion, and estimates statistical significance based on com-
paring this difference with a population of hundreds of
measurements of differential expression for different
genes. We believe this approach is safer because there are
usually not enough replicates to reliably estimate both the
mean and variance of a single gene in standard microarray
experiments.
The MAS5 algorithm [11] provides present/absent calls.
We find that including only genes found to be present in
every single chip provides a slight increase in the overlap
between different calibration protocols.
Affymetrix annotate their GeneChips by aligning the
probes to databases of genomic and transcript sequences
[25]. If at least 9 of the 11 probes in a probe set match per-
fectly to a transcript, the assignment is considered a high
quality assignment and is referred to by Affymetrix as a
Matching Probes assignment (grade A). Affymetrix (2004)
claim that over 70 percent of the probesets on the latest
Human and Mouse GeneChips have grade A annotations.
However, this leaves almost 30 percent of probe sets
which contain three or more probes that do not align to
transcripts for which they were designed. Moreover, the
latest rat chip has only one third of its probe sets classified
as A. Furthermore, on the older releases of GeneChips,
there is much greater use of EST information, and hence
more likely sources of errors. Thus many probes on Gene-
Chips will not align to the transcripts to which they are
assigned and there is a need to identify and remove such
spurious probes [7]. Another complication is that some
probes are found to match to more than one place in the
genome, and so are particularly prone to cross-hybridisa-
tion. Using the Dai et al. CDFs tailored to specific annota-
tion resources [6], we show that, irrespective of the
annotation source, the biggest cause of discrepancy
between gene lists from different calibration protocols is
the choice of expression measure.
Conclusion
We have systematically examined permutations of differ-
ent calibration protocols for the analysis of Affymetrix
GeneChips. Our results show that the lists of significant
genes identified by sliding Z-scores show a clear demarca-
tion between the different expression summaries. The
overlap in significant genes for a given expression meas-
ure, chosen with either different backgrounds or different
normalisations, is high, typically greater than 80%. These
findings apply irrespective of which annotation resource
has been used to assign probe mappings. Our results high-
light that the major uncertainty in the calibration of
Affymetrix microarray data is the choice of method in
transforming the multiple probe intensities into one
measure of expression.BMC Bioinformatics 2007, 8:195 http://www.biomedcentral.com/1471-2105/8/195
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Methods
1) Affymetrix Chips used in the analysis
The GeneChip data in this study was extracted from the
Gene Expression Omnibus database [26]. We extracted
the data from 5 experiments, which were given the GEO
IDs GSE1004, GSE1703, GSE1873, GSE2401 and
GSE2535. Our sample includes data from Human, Rat
and Mouse, chosen so we that we can assess whether our
conclusions are dependent upon the species. We also sam-
pled three experiments using HGU95Av2, chosen to see if
our conclusions alter for different data taken from within
a species.
a) GSE1004 [9] is a study of Duchenne Muscular Dystro-
phy (DMD) using Human HG-U95Av2 GeneChips.
mRNA taken from twelve quadriceps biopsies from DMD
patients was compared with twelve quadriceps biopsies
from unaffected controls. Analysis of the GEO data indi-
cates that one of the control chips cannot be analysed in
the same batch as the others, meaning that our analysis
compares twelve DMD chips versus eleven control chips.
b) GSE1703 [13] is a study of transcripts undergoing non-
sense mediated decay (NMD) using Human HG-U95Av2
GeneChips. Two chips had mRNA from cells with RENT1
knocked down through siRNA, and two chips had mRNA
from control cells.
c) GSE1873 [14] is a study of chronic intermittent hypoxia
in obese mice using Mouse MOE430A 2.0 GeneChips.
mRNA taken from five mice exposed to intermittent
hypoxia was compared with five mice exposed to inter-
mittent room air.
d) GSE2401 [15] is a study of the regulation of blood pres-
sure in rat using Rat RAE230A GeneChips. mRNA taken
from rats having acute hypotension induced by bleeding
using ventricular punction was compared with control
rats undergoing ventricular punction without bleeding.
Four chips were made using the hypotension rats and five
were made using the controls.
e) GSE2535 [16] is a study of gene expression changes
induced by Imatinib using Human HG-U95Av2 Gene-
Chips. mRNA was taken from diagnosed patients with
chronic myeloid leukaemia, from responders and nonre-
sponders to Imatinib, and from patients from either Leip-
zig or Mannheim. For our analysis we separated the data
of Crossman into just two groups, 16 chips for responders
and 12 for nonresponders
2) Calibration options
A welcome development in the field of microarray analy-
sis has been the Bioconductor project [27]. Bioconductor
aims to develop open-source tools (primarily in the lan-
guage R) for the analysis of genomic data. Many of the
statisticians researching numerical methods to deal with
microarray data are using R and making their algorithms
freely available through Bioconductor. The project is able
to provide sophisticated, up to date tools for microarray
analysis. Furthermore the project has a commitment to
providing documentation and support for the tools it pro-
vides. Moreover, the associated newsgroup allows novice
users to communicate directly with algorithm developers
as well as experienced users.
Several of the Bioconductor software libraries are dedi-
cated to the analysis of data from Affymetrix chips. The
package "affy" allows the development of customised cal-
ibration protocols. It allows, through the use of the rou-
tine "expresso", choices from various background
correction methods, normalisation routines and expres-
sion summaries (Table 1). Combining the three options
for Background correction, five for normalisation and
three for expression measure allows 45 possible calibra-
tion protocols.
2. i) Background correcting with affy
A proportion of an intensity measurement is not due to
binding of the target to the probe. Even blank areas on the
chips show some fluorescence and there will also be some
non-specific binding contributing to the intensity meas-
urement of a perfect match probe. Background correction
is a contentious issue and so affy allows a choice from
three.
One option is to simply ignore the background correction
step altogether. This choice acknowledges that current
background corrections may not successfully remove the
background without increasing the noise level – the result
of subtracting one noisy value from another noisy value is
more noisy than either of the original values. A second
option is that used by Affymetrix MAS 5.0 [11]. This
involves using areas of the chip with the lowest fluores-
cence as an estimate of background. It also uses the infor-
mation contained within the MM probes to estimate the
levels of cross-hybridisation. A further choice [10] which
estimates the background based on fitting a model to the
distribution of intensities on the chip.
2. ii) Normalisation options with affy
Arrays can be normalised by making the average intensity
on each array take the same average value. This "constant"
correction is either the average intensity of a chosen base-
line array or an arbitrary target intensity. A number of var-
iations on this theme are possible. For example, scaling to
housekeeping genes, using spiked-in mRNA's of known
concentration, or using a subset of the data with the least
variation between arrays. The Affy library allows the user
to choose "invariant set" as a normalisation option.BMC Bioinformatics 2007, 8:195 http://www.biomedcentral.com/1471-2105/8/195
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A single scale factor, applied to all values, makes the
assumption that the array effect is constant for all intensi-
ties. This does not appear to be the case for all microarray
data and suggests the need for non-linear normalisation.
Loess normalisation is a popular approach for dealing
with non-linear scaling. A curve is fitted to the fold
changes within a small intensity window. The values are
then scaled such that the average fold change becomes
zero within the window.
An alternative way to apply non-linear normalisation is to
use quantiles [28]. This method forces the intensity distri-
butions on each chip to be identical by ranking the inten-
sities, and resetting the intensity values at each rank across
all chips to be the mean of the intensities at that rank.
Each gene is given a normalised intensity value that
reflects its level of expression compared to all the other
genes on the array. Q-Spline [29] normalisation functions
like quantile normalisation, by forcing the intensities on
each chip to have the same distribution. However, Q-
Spline fits smoothing splines to the array and the target
array quantiles. These splines are then used as signal
dependent normalisation functions on the signals of the
array. In practise, quantile and Q-spline normalisation
produce very similar results.
Affy, via expresso, allows a choice from any of these five
normalisations: constant; invariant set; loess; qspline;
quantile.
2. iii) Calculating an Expression Measure with affy
A single Affymetrix GeneChip contains hundreds of thou-
sands of different oligonucleotides, each present in mil-
lions of copies. To identify a single gene transcript, upto
20 probe pairs are used. Each probe pair consists of a per-
fect match (PM) probe and a mis-match (MM) probe. The
MM is identical to the PM probe except for a single substi-
tution at the central position, and is designed to identify
non-specific hybridisation. Assuming a suitable normali-
sation and background subtraction have been performed,
the multiple PM and MM values must be condensed into
a single value as a measure of the expression of the tran-
script.
In early versions of Affymetrix's Microarray Analysis Suite
(MAS), versions 4.0 and below, the expression measure
used an "Average Difference" value: the mean of the PM-
MM values for a given probeset. The motivation for this
expression measure is simply that subtracting the MM
value from the associated PM should remove the mis-
match component of the PM intensity, and also the aver-
age over the adjusted PM values ought to result in an
estimate of the mRNA concentration in the sample.
Although widely used, Average Difference has found to be
a poor measure of expression level [12]. A more robust
measure called Signal has been introduced in MAS 5.0.
Signal is based on a weighted average of the log of PM-
MM [11].
An alternative philosophy for deriving an expression
measure takes advantage of the fact that all Affymetrix
chips of a given array design are created equal. This means
that the response of a probe set will be constant from chip
to chip. This allows a model to be made that measures
both the probe response pattern and the expression of
transcript on each chip [12]. Rather than taking each chip
in isolation, as in Signal, the model based methods look
at the responses across all the chips together. The model-
based approach implemented in the analysis software d-
chip is known as the Li and Wong method or the Model
Based Expression Index (MBEI). An alternative model-
based approach has been proposed [10] and is known as
the Robust Multichip Average (RMA). The two methods
use different models and different methods for parameter
estimation. In this study we use Li-Wong models based
only on the PM values.
3) We have used Z scores and T-tests as our measure of 
statistical significance of differential expression
Affymetrix data shows a non-linearity between signal
intensity and transcript concentration. At the low and
high ends of transcript concentration, a doubling in con-
centration results in a much lower change in fluorescent
intensity [30]. Because fold changes measure differences
in fluorescent intensity, they will therefore not be accu-
rately measuring the differences in transcript concentra-
tion. Chemical saturation of GeneChips is likely
responsible for the reduction in fold changes seen at high
intensities [19]. Similar non-linear scanner curves in stud-
ies using cDNA glass-spotted arrays [31], suggest many of
the physical processes underpinning the non-linearity
may be common to a number of microarray technologies.
We believe that the reduction in fold changes seen at low
intensities is likely due to cross-hybridisation between
probes and the general population of mRNA. Because the
population signal will be fairly constant between condi-
tions, and contributes a significant fraction of the fluores-
cent intensity, the observed fold change will not be
representative of the change in transcript abundance for
the gene of interest. A Z-score derived from fold changes
within a local intensity window corrects intensity depend-
ent effects apparent in two-colour arrays [1]. Applying this
methodology resulted in a list of significant genes that are
evenly spread across the intensity range, following the dis-
tribution of the underlying population.
We have chosen to follow this. The Z-score, in this
instance, is defined as the number of standard deviations
a probesets fold change is away from the mean foldBMC Bioinformatics 2007, 8:195 http://www.biomedcentral.com/1471-2105/8/195
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change (equation 1). The standard deviation, σ, and mean
fold change, μ, are derived from the population of genes
with similar intensities to the gene of interest. In our anal-
ysis we used a sliding window of 1%.
We have also produced gene lists for each experiment
using the standard t-test calculation. As we illustrate, the t-
tests lists are very sensitive to the choice of calibration pro-
tocol.
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